Back
Beam Therapeutics Stock Price Chart
Sponsored
BEAM
Sponsored
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Sell
26
BEAM
Beam Therapeutics
Last Price:
24.32
Seasonality Move:
24.38%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BEAM is experiencing slight selling pressure.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.19 | Sell |
20-day SMA: | 29.55 | Sell |
50-day SMA: | 32.89 | Sell |
200-day SMA: | 27.55 | Sell |
8-day EMA: | 26.09 | Sell |
20-day EMA: | 28.79 | Sell |
50-day EMA: | 30.59 | Sell |
200-day EMA: | 30.28 | Sell |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.45 | Sell |
Relative Strength Index (14 RSI): | 26.09 | Sell |
Chaikin Money Flow: | -390606 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.9 - 34.28) | Sell |
Bollinger Bands (100): | (25.46 - 34.58) | Sell |
Beam Therapeutics Technical Analysis
Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 24.31 while BEAM 8-day simple moving average is 26.19, which is a Sell signal.
- The stock price of BEAM is 24.31 while Beam Therapeutics 20-day SMA is 29.55, which makes it a Sell.
- Beam Therapeutics 50-day simple moving average is 32.89 while BEAM share price is 24.31, making it a Sell technically.
- BEAM stock price is 24.31 and Beam Therapeutics 200-day simple moving average is 27.55, creating a Sell signal.
BEAM Technical Analysis vs Fundamental Analysis
Sell
26
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a Sell
The current Beam Therapeutics [BEAM] share price is $24.31. The Score for BEAM is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Beam Therapeutics Stock Info
Market Cap:
1.99B
Price in USD:
24.31
Share Volume:
1.36M
Beam Therapeutics 52-Week Range
52-Week High:
49.50
52-Week Low:
16.95
Sell
26
Beam Therapeutics (BEAM)
is a Sell
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?
The Beam Therapeutics stock price is 24.31 USD today. -
Will BEAM stock go up or go down?
Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Beam Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is overvalued.
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 24.31 while BEAM 8-day exponential moving average is 26.09, which is a Sell signal.
- The stock price of BEAM is 24.31 while Beam Therapeutics 20-day EMA is 28.79, which makes it a Sell.
- Beam Therapeutics 50-day exponential moving average is 30.59 while BEAM share price is 24.31, making it a Sell technically.
- BEAM stock price is 24.31 and Beam Therapeutics 200-day simple moving average is 30.28, creating a Sell signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.01 per share, a decrease this year of $1.09 per share, and an increase next year of $0.22 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
- BEAM Moving Average Covergence Divergence (MACD) indicator is -2.45, suggesting Beam Therapeutics is a Sell
- Beam Therapeutics Relative Strength Index (RSI) is 26.09, which suggest Beam Therapeutics is oversold
- The Bollinger Bands (25) for Beam Therapeutics is (26.9 - 34.28), which suggest Beam Therapeutics is a Sell
- The Bollinger Bands (100) for Beam Therapeutics is (25.46 - 34.58), which suggest Beam Therapeutics is a Sell
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.